BusinessOcera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®By Nasdaq OMXOct 20, 2017, 11:30 AM UTC
BusinessOcera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017By Nasdaq OMXAug 23, 2017, 1:05 PM UTC
BusinessOcera Therapeutics Announces Late-Breaker Abstract Accepted for Presentation at the AASLD Liver Meeting 2016By Nasdaq OMXOct 24, 2016, 1:05 PM UTC
BusinessOcera Announces Enrollment Completion From Phase 2a NIH-Sponsored Study of OCR-002 in the Treatment of Patients with Acute Liver FailureBy Nasdaq OMXSep 21, 2016, 8:05 PM UTC
